Evidence map›Paper›PMID 31865404›Full record

ArticleDiabetologia2020

Incidence and relative risk of renal replacement therapy in people with and without diabetes between 2002 and 2016 in a German region.

Maria Narres, Heiner Claessen, Tatjana Kvitkina, Michael Koch, Lars Christian Rump, Thomas Weinreich, Andrea Icks

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Maria NarresInstitute for Health Services Research and Health Economics, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research at Heinrich-Heine-University Düsseldorf, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany.
Heiner ClaessenInstitute for Health Services Research and Health Economics, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research at Heinrich-Heine-University Düsseldorf, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany. heiner.claessen@ddz.de.ORCID 0000-0002-9818-413X
Tatjana KvitkinaInstitute for Health Services Research and Health Economics, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research at Heinrich-Heine-University Düsseldorf, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany.
Michael KochCentre of Nephrology, Mettmann, Germany.
Lars Christian RumpDepartment of Nephrology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Thomas WeinreichCenter of Nephrology, Villingen-Schwenningen, Germany.
Andrea IcksInstitute for Health Services Research and Health Economics, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research at Heinrich-Heine-University Düsseldorf, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany.
Deutsches Diabetes-Zentrum e.V. · DEDüsseldorf University Hospital · DENephrologisches Zentrum Villingen-Schwenningen · DE

Funding

German Federal Ministry of Health ZMV I 5-2514FSB505
6 · The paper itself

Abstract

aims/hypothesisData on trends of end-stage renal disease among people with diabetes are lacking. We analysed the incidence of end-stage renal disease, defined as renal replacement therapy, among people with and without diabetes, and the corresponding relative risk. Moreover, we investigated time trends for the period 2002-2016.

methodsIn this retrospective population-based study we analysed data from one dialysis centre of a region in Germany covering a population of about 310,000 inhabitants. We estimated the age- and sex-standardised incidence rates for chronic renal replacement therapy among adults with and without diabetes and the corresponding relative risks. The time trend was analysed using Poisson regression models.

resultsBetween 2002 and 2016, 1107 people (61.2% male; mean age 71.6 years; 48.7% with diabetes) had a first renal replacement therapy. During the study period, the incidence rate in the population with diabetes varied from 93.6 (95% CI 50.4, 136.7) in 2002 to 140.5 (95% CI 80.6, 200.4) in 2016 per 100,000 person-years. In the population without diabetes the incidence rate was substantially lower and reached 17.3 (95% CI 10.9, 23.6) in 2002 and 24.6 (95% CI 17.5, 31.7) in 2009. The relative risk comparing people with and without diabetes was 3.57 (95% CI 3.09, 4.13). No significant change in the incidence rates was found during the observation period, either in the population with or in the population without diabetes, and thus the relative risk also remained constant. CONCLUSIONS/

interpretationPeople with diabetes have a higher risk of needing renal replacement therapy than those without diabetes, a fact that remained constant over a time period of 15 years.

Indexed as

Diabetic NephropathiesKidney Failure, ChronicRenal Replacement TherapyAdultAgedAged, 80 and overDiabetes Mellitus, Type 2FemaleGermanyHumansIncidenceMaleMiddle AgedPrognosisRetrospective StudiesRiskDiabetesEnd-stage renal diseaseEpidemiologyIncidenceRenal replacement therapy

Identifiers

PMID31865404
OpenAlexW2995186301

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.